Commercialization: Page 31
-
PharmaVoice Team/PharmaVoice
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to pay it forward. Philanthropy is a big part of what makes our inspired leaders tick. They generously give of their time and resources. Download PDF
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Creatives
Stephanie McGee Mentoring Creativity Title: Executive Creative Director Company: Fingerpaint Marketing (Conshohocken, Pa.) Education: BA, Communication, Arts and Graphic Design, Mount Mary University Family: Mom, Gemman, for her open-mind and her free spirit to think outside the box; Dad, Ditmar,...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Marketers
Mark Finn Winning the Game One Pitch at a Time Title: VP, Account Director Company: AbelsonTaylor Education: MBA, Kellogg School of Management Family: Wife, Amy, for her continual support, as Winston Churchill said: “My most brilliant achievement was my ability to be able to persuade my wife to m...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Alternative Jobs
What other job would you like to attempt? They may be industry stars today, but many of our PharmaVOICE 100 discuss what they would have liked to pursue. Download PDF
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Trial transformation IBM Watson, Microsoft, Oracle, GE are among the dozens, if not hundreds, of companies that are developing and deploying game-changing technologies, tools, services, and processes focused on transforming how clinical trials are conducted. The goals are lofty, and the stakes ar...
By Taren Grom • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Allergan Encourages Those with Migraine to Share Experiences Through Art Allergan has unveiled Frames of Mind, an interactive campaign to promote awareness of the impact that migraine can have on patients’ everyday lives. People living with migraine are encouraged to create art submissions that v...
By PharmaVoice Team • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Bringing Patients’ Voices to Drug Development Sudip Parikh, Senior VP and Managing Director of DIA Americas, talks about the Drug Information Association’s survey of patient-centric initiatives in drug development. PV: What are the notable findings fromDIA’s survey about patient-centricity in dr...
By Sudip Parikh • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Marketing Mashup: Client and Agency Do's and Don'ts
A true partnership is a rare find, and when a pharma client and an ad agency develop one, magical things happen. Much like any relationship, these partnerships take chemistry, communication, transparency, trust, and commitment. Also, setting expectations clearly and up front helps smooth the part...
By Robin Robinson • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Supply and Demand: Getting Rare Disease Treatments to Patients
Collectively, about 7,000 different types of rare diseases affect around 350 million patients globally. A disease is considered rare if it affects fewer than 200,000 people in the United States or one in 2,000 people in Europe, but the burden such diseases place on patients, communities, and heal...
By Kim Ribbink • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Improved Patient-Centricity Means Improved Patient Diversity Too
Increasing the diversity of patients enrolled in clinical trials of new medicines has become a growing theme for improving the clinical trial process. There is broad recognition that research participants need to be representative of the patient population who will ultimately use the product. Res...
By Scott Gray • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Accelerating the Shift to Digital in Life Sciences
An unprecedented wave of value is about to explode for pharmaceuticals companies and medical device makers that embrace digital approaches to doing business. Digital mastery will result in renewed opportunities for life sciences companies to forge deeper connections in the currently fragmented in...
By Bhaskar Sambasivan • June 1, 2017 -
PharmaVoice Team/PharmaVoice
eConsent: Reducing Uncertainty to Retain Patients
Imagine you’re applying for a new bank account. A bank associate guides you through forms, pointing at where your signature belongs. He’s got good intentions and wants to help, but speaks quickly with jargon and acronyms. You leave feeling cautiously optimistic, as you still have questions. Weeks...
By Eric Delente • June 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The act of giving In this month’s cover story, we shine a light on the philanthropic and social responsibility initiatives being undertaken by just a few life-sciences companies. In fact, pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable ...
By Taren Grom • May 1, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
Pregnant Women, an Understudied Population, Get Insights App Trend Watch: ResearchKit, VR, and other tech innovations are improving patient monitoring. WebMD and Scripps Translational Science Institute have launched a study to understand factors that contribute to healthy pregnancies, using WebMD...
By PharmaVoice Team • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Better Monitoring of Opioids Purdue Pharma’s VP and Chief Medical Officer, Gail Cawkwell, M.D., Ph.D., talks about the need to integrate state prescription monitoring programs — state-run electronic databases to track prescribing and dispensing of controlled prescription drugs — with electronic h...
By Gail Cawkwell • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Philanthropy: Beyond the Numbers
Pharmaceutical companies — and the industry as a whole — are at the top of many lists in terms of charitable giving, philanthropy, and corporate responsibility. Over the years, pharma has repeatedly been named as a top industry corporate donor, rivaled only by the finance industry. The Reputation...
By PharmaVoice Team • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Behind the Brand — Lessons Learned
According to the global branding and design firm Landor, the process of managing brands — or brand governance — has changed dramatically in recent years. The command-and-control model is obsolete in today’s more agile and dynamic marketplace. In this new world, multiple communities, including em...
By Robin Robinson • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Hepatitis Market Update
In just a few short years, hepatitis infections could go from a serious disease to one that will be rare. Pharmaceutical companies have done much to address hepatitis in recent years. Today, hepatitis B is preventable with vaccination, and recent advances in treatment have made hepatitis C curabl...
By Denise Myshko • May 1, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: mHealth: Seeing the Potential in mHealth
Mobile is ubiquitous. Consumers use mobile apps to search for information about everything from retail products to news and sports and, increasingly, to monitor their health. A report from comScore found that mobile now represents 65% of digital media time, and that desktop computers are becoming...
By PharmaVoice Team • May 1, 2017 -
PharmaVoice Team/PharmaVoice
The Impact of mHealth on Real-World Data Collection
Advancements in technology over the past five years have led to increased interest around the topic of mHealth — the monitoring and delivery of healthcare through mobile devices. Approximately 93% of us now own a mobile phone and, with an increased desire from the pharmaceutical industry to use e...
By PharmaVoice Team • May 1, 2017 -
PharmaVoice Team/PharmaVoice
A Patient-Centric Approach to mHealth
The possibilities for mHealth solutions are vast and expanding, so how can pharmaceutical brands know how to enter the space, or even if they should? Consider Your Patients First Patients are actively searching for ways to live healthier lives, prevent illness, manage chronic conditions, and keep...
By Dara Liguori • May 1, 2017 -
PharmaVoice Team/PharmaVoice
mHealth Evolution
Ten years after the launch of Apple’s iPhone in 2007, mobile healthcare (mHealth) technology and consumer adoption continues to advance. mHealth is a general term for the use of mobile wireless technology for medical care, health, and fitness. As the global population moves from being digitally n...
By Brandie Linfante • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Speak Out
Welcome to the Jungle: The Dilemma of the Healthcare Challenger Brand Marketing a pharmaceutical product or medical device to a healthcare professional audience has changed radically, even for market leaders and establishment brands. But for challenger brands—the brands with something to prove, o...
By Frank X. Powers • May 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Working in concert The act of collaborating with competitors, no less with companies and organizations outside of traditional “pharma," was a concept that might have been considered heresy — until recently. Sure, there were agreements with academic centers or cross-licensing deals to capitalize o...
By Taren Grom • April 1, 2017
Previous
